- SUPPLEMENTS AND VITAMINS42 products
- Acute Myeloid Leukemia1 product
- ANTI CANCER157 products
- ANTI DIABETES44 products
- ANTI-ANXIETY3 products
- Antiulcerants1 product
- ANTY BODY8 products
- Arthritis2 products
- Bacterial infections1 product
- BEAUTY PRODUCTS19 products
- BLOOD CANCER13 products
- BREAST CANCER37 products
- Chemotherapy49 products
- GYNAE1 product
- HEPATITIS C VIRUS27 products
- HER2 POSITIVE BREAST CANCER1 product
- JANUS KINASE (JAK) INHIBITOR5 products
- KIDNEY DISEASES16 products
- LEUKEMIA1 product
- Liver Fibrosis1 product
- LUNG CANCER2 products
- MENTLE CELL LYMPHOMA (CLL)1 product
- Oncology Medicine12 products
- Phosphate Binder1 product
- PROSTATE CANCER16 products
- SEXUAL HEALTH10 products
- SKIN & HAIR CARE11 products
- Therapeutic1 product
- Thrombocytopenia1 product
- Thrombopoietin1 product
- URINARY DISORDERS1 product
-
Ruxotor 5 mg
Ruxotor 5 mg (Ruxolitinib) by Everest Pharmaceuticals is a JAK1/JAK2 inhibitor used in the management of myelofibrosis, polycythemia vera, and graft-versus-host disease, helping to improve survival and reduce disease symptoms.
-
Ruxotor 10 mg
đźź© Ruxotor 10 mg Generic Name: Ruxolitinib Phosphate INNBrand Name: RuxotorManufacturer: Everest Pharmaceuticals Ltd.Strength & Form: 10 mg | Film-coated tabletsPack Size: 60 tablets đź“Ś Indications: Ruxotor (Ruxolitinib) is indicated for the treatment of: Myelofibrosis (MF): including primary myelofibrosis, post–polycythemia vera MF, and post–essential thrombocythemia MF. Polycythemia Vera (PV): in patients resistant or intolerant to…
-
Lazerib 80 mg
azerib 80 mg (Lazeritinib) by Everest Pharmaceuticals is a third-generation EGFR TKI, used in the treatment of EGFR-mutant advanced or metastatic non-small cell lung cancer (NSCLC), including cases resistant to earlier TKIs.
-
Tirzix 7.5 mg
Tirzix 7.5 mg Generic Name: TirzepatideBrand: TirzixStrength: 7.5 mgManufacturer: Beacon Pharmaceuticals Ltd.Dosage Form: Prefilled Pen / Subcutaneous Injection Description: Tirzix 7.5 mg is a once-weekly subcutaneous injection of Tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It is used to improve glycemic control in adults with type 2 diabetes mellitus. Tirzix offers a dual-action approach, enhancing insulin…
-
Tirzix 5 mg
Tirzix 5 mg Generic Name: TirzepatideStrength: 5 mgManufacturer: Beacon Pharmaceuticals Ltd.Form: Subcutaneous Injection (Prefilled Pen or Vial) Description: Tirzix 5 mg contains Tirzepatide, a novel dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It is used as a once-weekly injectable medication primarily indicated for type 2 diabetes mellitus and shows promising results in weight management and metabolic control. Tirzix offers a unique mechanism that enhances insulin…
